Alport syndrome or progressive hereditary nephritis with hearing loss;Syndrome d'Alport ou néphropathie héréditaire hématurique progressive avec surdité

Nephrologie et Therapeutique

Volumn 3, Issue 3, 2007, Pages 113-120

  Gubler, Marie Claire ^a   Heidet, Laurence ^a   Antignac, Corinne ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Alport syndrome; COL4A3; COL4A4; COL4A5; COL4A6; Diffuse leiomyomatosis; Giant platelet disorder; Glomerular basement membrane; Type IV collagen

Indexed keywords

COLLAGEN TYPE 4; CYCLOSPORIN A;

ALPORT SYNDROME; GENE MUTATION; HEARING LOSS; HUMAN; IMMUNOFLUORESCENCE; KIDNEY FAILURE; SHORT SURVEY; X CHROMOSOME LINKED DISORDER; ARTICLE; BASEMENT MEMBRANE; DISEASE COURSE; DOMINANT GENE; GENETICS; GLOMERULUS; HEMATURIA; NEPHRITIS; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS;

BASEMENT MEMBRANE; DISEASE PROGRESSION; GENES, DOMINANT; HEARING LOSS; HEMATURIA; HUMANS; KIDNEY GLOMERULUS; NEPHRITIS, HEREDITARY; PROGNOSIS;

EID: 34249287054     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2007.03.005     Document Type: Short Survey

References (50)

1. Timpl R. Structure and biological activity of basement membrane proteins. Eur. J. Bioch. 180 (1989) 487-502
2. Hudson B.G., Tryggvason K., Sundaramoorthy M., and Neilson E.G. Alport's syndrome, Goopasture's syndrome and type IV collagen. N. Engl. J. Med. 348 (2003) 2543-2556
3. Soininen R., Huotari M., Hostikka S.L., Prockop D.J., and Tryggvason K. The structural genes for alpha1 and alpha2 chains of human type IV collagen are divergently encoded on opposite DNA strands and have an overlapping promoter region. J. Biol. Chem. 263 (1988) 17217-17220
4. Hostikka S.L., Eddy R.L., Byers M.G., Hoyhtya M., Shows T.B., and Tryggvason K. Identification of a distinct type IV collagen α chain with restricted kidney distribution and assignment of its gene to the locus of X-linked Alport syndrome. Proc. Natl. Acad. Sci. USA 87 (1990) 1606-1610
5. Mariyama M., Zheng K., Yang-Feng T.L., and Reeders S.T. Colocalization of the genes for the α3(IV) and α(IV) chains of type IV collagen to chromosome 2 bands q35-q37. Genomics 13 (1992) 809-813
6. Zhou J., Mochizuki T., Smeets H., Antignac C., Laurila P., de Paepe A., et al. Deletion of the paired α5(IV) and α6(IV) collagen genes in inherited smooth muscle tumors. Science 261 (1993) 1167-1169
7. Ninomiya Y., Kagawa M., Iyama K., Naito I., Kishiro Y., Seyer J.M., et al. Differential expression of two basement membrane collagen genes COL4A5 and COL4A6, demonstrated by immunofluorescence staining using peptide-specific monoclonal antibodies. J. Cell Biol. 130 (1995) 1219-1229
8. Alport A.C. Hereditary familial congenital haemorrhagic nephritis. BMJ 1 (1927) 504-506
9. Atkin C.L., Gregory M.C., and Border W.A. Alport syndrome. In: Schrier R.W., and Gottschalk C.W. (Eds). Diseases of the kidney (1988), Little Brown, Boston 617-641
10. Gubler M.C., Antignac C., Deschênes G., Knebelmann B., Hors-Cayla M.C., Grünfeld J.P., et al. Hétérogénéité génétique, clinique et morphologique dans le syndrome d'Alport. In: Funck-Brentano J.L., Bach J.F., Kreis H., and Grünfeld J.P. (Eds). Actualités Néphrologiques (1992), Flammarion Médecine-Sciences, Paris 15-33
11. Nielsen C.E. Lenticonus anterior and Alport syndrome. Acta Ophthalmol. (Copenh.) 56 (1977) 518-530
12. Polack B.C.P., and Hogewind B.L. Macular lesions in Alport's disease. Am. J. Ophthalmol. 84 (1977) 533-535
13. Sohar E. Renal disease, inner ear deafness, and ocular changes: new heredofamilial syndrome. Arch. Intern. Med. 97 (1956) 627-630
14. Epstein C.J., Sahud M.A., Piel C.F., et al. Hereditary macrothrombocytopathia, nephritis and deafness. Am. J. Med. 52 (1972) 299-310
15. Churg J., and Sherman R.L. Pathologic characteristics of heteditary nephritis. Arch. Pathol. 95 (1973) 374-379
16. Hinglais N., Grünfeld J.P., and Bois E. Characteristic ultrastructural lesion of the glomerular lesion of the glomerular basement membrane in progressive hereditary nephritis (Alport's syndrome). Lab. Invest. 27 (1972) 473-487
17. Spear G.S., and Slusser R.J. Alport's syndrome: emphasizing electron microscopic studies of the glomerulus. Am. J. Pathol. 69 (1972) 213-224
18. Gubler M.C., Knebelmann B., Beziau A., Broyer M., Pirson Y., Haddoum F., et al. Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution. Kidney Int. 47 (1995) 1142-1147
19. Kashtan C.E., Kleppel M.M., and Gubler M.C. Immunohistochemical findings in Alport syndrome. In: Tryggvason K. (Ed). Molecular Pathology and genetics of Alport syndrome (1996), Karger, Basel 142-153
20. Mazzucco G., Barsotti P., Muda A.O., Fortunato M., Mihatsch M., Torri-Tarelli L., et al. Ultrastructural and immunohistochemical findings in Alport's syndrome: a study of 108 patients from 97 Italian families with particular emphasis on COL4A5 gene mutation correlations. J. Am. Soc. Nephrol. 9 (1998) 1023-1031
21. Feingold J., Bois E., Chompret A., Broyer M., Gubler M.C., and Grünfeld J.P. Genetic heterogenerity of Alport syndrome. Kidney Int. 27 (1985) 672-677
22. Gubler M.C., Heidet L., and Antignac C. Alport's syndrome, thin basement membrane nephropathy, nail patella syndrome, and type III collagen glomerulopathy. In: Jennette J.C., Olson J.L., Schwartz M.M., and Silva F.G. (Eds). Heptinstall's Pathology of the Kidney, 6th ed (2007), Lippincott Williams & Wilkins Publishers, Philadelphia 496-515
23. Jais J.P., Knebelmann B., Giatras I., De Marchi M., Rizzoni G., Renieri A., et al. X-linked Alport syndrome. Natural history in 195 families and genotype-phenotype correlations in males. J. Am. Soc. Nephrol. 11 (2000) 649-657
24. Jais J.P., Knebelmann B., Giatras I., De Marchi M., Rizzoni G., Renieri A., et al. X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a « European Community Alport's syndrome Concerted Action Study ». J. Am. Soc. Nephrol. 14 (2003) 2603-2613
25. Rhys C., Snyers B., and Pirson Y. Recurrent corneal erosion associated with Alport's syndrome. Kidney Int. 52 (1997) 208-211
26. Naito I., Shinichiro K., Nomura S., Sado Y., Osawa G., and and the Japanese Alport Network. Relationship between COL4A5 gene mutation and distribution of type IV collagen in male X-linked Alport syndrome. Kidney Int. 50 (1996) 304-312
27. Heidet L., Cai Y., Guicharnaud L., Antignac C., and Gubler M.C. Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys. Am. J. Pathol. 156 (2000) 1901-1910
28. Barker D.F., Hostikka S.L., Zhou J., Chow L.T., Oliphant A.R., Gerken S.C., et al. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 247 (1990) 1224-1227
29. Antignac C., Knebelmann B., Drouot L., Gros F., Deschênes G., Hors-Cayla M.C., et al. Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in non-renal cells and correlation with disease expression. J. Clin. Invest. 93 (1994) 1195-1207
30. Tryggvason K. Mutations in type IV collagen genes and Alport phenotypes. In: Tryggvason K. (Ed). Contrib Nephrol: Molecular pathology and genetics of Alport syndrome (1996), Karger, Basel 154-171
31. Heikkilä P., and Soininen R. The type IV collagen family. In: Tryggvason K. (Ed). Contrib Nephrol,: Molecular Pathology and genetics of Alport syndrome (1996), Karger, Basel 105-129
32. Knebelmann B., Breillat C., Forestier L., Arrondel C., Jacassier D., Giatras I., et al. Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome. Am. J. Hum. Genet. 59 (1996) 1221-1232
33. Lemmink H.H., Schröder C.H., Monnens L.A.H., and Smeets H.J.M. The clinical spectrum of type IV collagen mutation. Hum. Mutat. 9 (1997) 477-499
34. Renieri A., Bruttini M., Galli L., Zanelli P., Neri T., Rossetti S., et al. X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene. Am. J. Hum. Genet. 58 (1996) 1192-1204
35. Heidet L., Dahan K., Zhou J., Xu Z., Cochat P., Gould J.D.M., et al. Deletions of both a5(IV) and a6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumours. Hum. Mol. Genet. 4 (1995) 99-108
36. Boye E., Mollet G., Forestier L., Cohen-Solal L., Heidet L., Cochat P., et al. Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome. Am. J. Hum. Genet. 63 (1998) 1329-1340
37. Heidet L., Arrondel C., Cohen-Solal L., Forestier L., Mollet G., Gutierrez B., et al. Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome. J. Am. Soc. Nephrol. 12 (2001) 97-106
38. Van der Loop F.T., Heidet L., Timmer E.D., van den Bosch B.J., Leinonen A., Antignac C., et al. Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney Int. 58 (2000) 1870-1875
39. Pescucci C., Mari F., Longo I., Vogiatzi P., Caselli R., Scala E., et al. Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene. Kidney Int. 65 (2004) 1598-1603
40. Kharrat M., Makni S., Makni K., Kammoun K., Charfeddine K., Azaeiz H., et al. Autosomal dominant Alport's syndrome: study of a large Tunisian family. Saudi J Kidney Dis Transpl. 17 (2006) 320-325
41. Arrondel C., Vodovar N., Knebelmann B., Grunfeld J.P., Gubler M.C., Antignac C., et al. Expression of the non-muscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J. Am. Soc. Nephrol. 13 (2002) 65-74
42. Zheng K., Thorner P.S., Marrano P., Baumal R., and McInnes R.R. Canine X chromosome-linked hereditary nephritis: a genetic model for human X-linked hereditary nephritis resulting from a single base mutation in the gene encoding the α5 chain of collagen type IV. Proc. Natl. Acad. Sci. USA 91 (1994) 3989-3993
43. Cosgrove D., Meehan D.T., Grunkemeyer J.A., Kornak J.M., Sayers R., Hunter W.J., et al. Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome. Genes Dev. 10 (1996) 2981-2992
44. Miner J.H., and Sanes J.R. Molecular and functional defects in kidneys of mice lacking collagen a3(IV): implications for Alport syndrome. J Cel Biol 135 (1996) 1403-1413
45. Heidet L., Borza D.B., Jouin M., Sich M., Mattei G., Sado Y., et al. A human-mouse chimera of the α3α4 α5(IV) collagen protomer rescues the renal phenotype in Col4a3-/- mice. Am. J. Pathol. 163 (2003) 1633-1644
46. Rogers P.W., Kurtzman N.A., Bunn S.M., and White M.G. Familial benign essential hematuria. Arch. Intern. Med. 131 (1973) 257-262
47. Schröder C.H., Bontemps C.M., Assmann K., et al. Renal biopsy and family studies in 65 children with isolated hematuria. Acta. Paediatr. Scand. 79 (1990) 630-636
48. Callis L., Vila A., Carrera M., and Nieto J. Long-term effects of cyclosporine A in Alport's syndrome. Kidney Int. 55 (1999) 1051-1056
49. Legato A., Emma F., and Massella L. Cyclosporine A treatment in pediatric patients with X-linked Alport syndrome: a single centre experience. Pediatr. Nephrol. 21 (2006) 1510
50. Charbit M., Gubler M.C., Dechaux M., Gagnadoux M.F., Grünfeld J.P., and Niaudet P. Cyclosporin therapy in patients with Alport syndrome. Pediatr. Nephrol. 22 (2007) 57-63